Stryker declares a $0.695 per share quarterly dividend
Stryker (NYSE:SYK) announced a quarterly dividend increase to $0.695 per share, payable on January 31, 2022, to shareholders of record as of December 31, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Stryker (NYSE:SYK) announced a quarterly dividend increase to $0.695 per share, payable on January 31, 2022, to shareholders of record as of December 31, 2021. This marks a 10.3% increase compared to the previous year and quarter. CEO Kevin Lobo emphasized the company's strong sales growth and solid financial results, aligning with their capital allocation strategy. Stryker is recognized as a leading medical technology firm, focused on improving healthcare through innovative products across Orthopaedics, Medical and Surgical, and Neurotechnology and Spine.
Positive
- 10.3% increase in quarterly dividend from the previous year and quarter.
- Strong sales growth reported despite challenging market conditions.
- Alignment with stated capital allocation strategy indicates company confidence.
Negative
- None.
Details
News Market Reaction – SYK
The recorded move for SYK in the trading session of this news was -0.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Kalamazoo, Michigan, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of
“Despite a challenging environment, we continue to deliver strong sales growth and drive solid financial results, and consistent with our stated capital allocation philosophy, we are raising our dividend
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:
Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.